Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Atossa Genetics Inc | 11 | 0 | 0 | 0 | €1.21 | €5.49 | 353.421% |
| Zoetis Inc. A | 24 | 1 | 0 | 0 | €166.28 | €198.11 | 19.143% |
| WAVE Life Sciences Ltd | 7 | 0 | 0 | 0 | €5.00 | €14.91 | 198.118% |
| Sutro Biopharma Inc | 21 | 0 | 0 | 0 | €4.06 | €11.04 | 171.980% |
| Davita Inc. | 5 | 1 | 0 | 0 | €136.15 | €132.72 | -2.520% |
| Intuitive Surgical Inc | 37 | 0 | 2 | 0 | €438.05 | €414.56 | -5.363% |
| Galmed Pharmaceuticals Ltd. | 13 | 0 | 1 | 0 | €2.84 | €68.81 | 2322.711% |
| Axonics Modulation Technologies Inc | 5 | 0 | 0 | 0 | €62.00 | €66.12 | 6.639% |
| BioMarin Pharmaceutical Inc. | 23 | 0 | 0 | 0 | €82.96 | €102.48 | 23.525% |
| Becton, Dickinson & Co. | 10 | 0 | 0 | 0 | €219.30 | €257.91 | 17.605% |
| Pulmatrix Inc. | 1 | 1 | 0 | 0 | €1.75 | €3.00 | 71.429% |
| Universal Health Services B | 14 | 6 | 0 | 0 | €216.00 | €150.90 | -30.138% |
| Alnylam Pharmace. | 46 | 1 | 1 | 1 | €229.80 | €270.16 | 17.564% |
| iRhythm Technologies Inc | 15 | 1 | 0 | 1 | €63.50 | €114.25 | 79.915% |
| Bayer AG | 18 | 6 | 0 | 4 | €27.73 | €45.00 | 62.279% |